Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Prader-Willi Syndrome market. The report analyses the Global Prader-Willi Syndrome Therapeutics Market in terms of its sizing, growth and forecast. The report presents a comprehensive pipeline assessment that includes DCCR (Soleno Therapeutics), Levolitide (Millendo Therapeutics) and Tesomet (Saniona). Also, the report analyzes the prevalence of PWS and profiles the leading companies operating in the PWS Therapeutics market. The report analyzes the Global Market, European Region Market and the country analysis of United States and Japan for the historical period of 2017 and 2018 and the forecast period of 2019-2024.

According to Azoth Analytics research report, the Prader-Willi Syndrome therapeutics market is projected to display a robust growth represented by a CAGR of 4.6% during 2019 2024.

Over the recent years, the Prader-Willi Syndrome market has been witnessing considerable growth directly on the back of the increasing number of diagnosed patients population. Moreover, growing human growth hormone therapy coverage rate, surging awareness and increasing government involvement have been driving the market.
Further, expected launch of novel therapies, such as DCCR (Soleno Therapeutics), Livoletide (Millendo Therapeutics), Testomet (Saniona AB) among others are anticipated to fuel the market growth.

The report titled report Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 2024) has covered and analyzed the potential of Prader-Willi Syndrome market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges, opportunities and market entry strategies for various companies. Additionally, the report also highlights the estimated prevalence of Prader-Willi Syndrome in USA, Europe and Japan.

Scope of the Report

Global Prader-Willi Syndrome Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
Prader-Willi Syndrome Market Size, Growth, Forecast
Prader-Willi Syndrome Market: Pipeline Analysis
o DCCR (Soleno Therapeutics)
o Levolitide (Millendo Therapeutics)
o Tesomet (Saniona)

Regional Prader-Willi Syndrome Market U.S.A, Europe, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)
Prader-Willi Syndrome Market Size, Growth, Forecast
Prader-Willi Syndrome Market: Pipeline Analysis
o DCCR (Soleno Therapeutics)
o Levolitide (Millendo Therapeutics)
o Tesomet (Saniona)

Other Report Highlights
Pipeline Analysis.
Competitive Landscape.
Product Benchmarking.
Market Dynamics Drivers and Restraints.
Market Trends.
Porter Five Forces Analysis.
SWOT Analysis.
Company Analysis Pfizer, Novartis, Novo Nordisk, Soleno Therapeutics, Saniona